Company Overview of KannaLife Sciences, Inc.
KannaLife Sciences, Inc., a bio-pharmaceutical and phyto-medical technology company, engages in the research and development of natural and phyto-medical products for use in health and wellness regimens. It specializes in the research and development of novel therapeutic agents to reduce oxidative stress, and act as immuno-modulators and neuroprotectants; and pharmacological products derived from plants. The company develops cannabinoid(s) and cannabidiol(s) based therapeutics to treat hepatic encephalopathy in humans. The company was founded in 2010 and is based in West Hills, New York with additional offices in New York.
363 West Hills Road
West Hills, NY 11743
Founded in 2010
Key Executives for KannaLife Sciences, Inc.
KannaLife Sciences, Inc. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact KannaLife Sciences, Inc., please visit www.kannalife.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.